Abstract
Objectives: This study aimed to assess prevalence of resistant hypertension (RHT) in hemodialysis (HD)
patients.
Patients and Methods: We conducted a cross sectional study on 135 HD patients. RHT was defined as
failure to reach target blood pressure (BP) control (systolic BP <140 mmHg and diastolic BP < 90 mmHg)
with maximal dose of 3 antihypertensive therapies (AHT) including diuretics in patients with good daily
urine output (> 500 cc/day) or at least 2 L/session ultrafiltration volume in oliguric (<500-100 cc/day) or
anuric patients (< 50 cc /day). Patients with post HD hypertension underwent 24h ambulatory monitor for
their BP, which hourly measured their BP.
Results: In our study; 34 (25.2%) of patients were non hypertensives, 43 (31.8%) were controlled
hypertensives, 58 (43.0%) were uncontrolled hypertensives. Uncontrolled hypertensives with inadequate
AHT were 53 (39.2 %), where RHT patients were 5 (3.7%)of all study population.
Conclusions: We concluded that RHT had3.7% prevalence in HD patients